Pharma IQ Glossary: Endpoint
An Endpoint is defined as the point at which an experimental animal's pain and/or distress is terminated, minimized or reduced by taking actions such as humanely killing the animal, terminating a painful procedure, or giving treatment to relieve pain and/or distress.
Controversy Around Clinical Trials Approval Endpoints - US Regulatory History of Avastin at Optimising Clinical Development in Oncology
January 05 by Pharma IQ NewsGary Acton, CMO from Antisoma will explore the challenges the contemporary controversy around clinical trials approval faces at Optimising Clinical Development in Oncology, 15th-16th March 2011 in Lon...
Bringing Innovation to Clinical Design
September 28 by Pharma IQClinical trials may be one of the most fundamental parts of drug development work carried out in the pharmaceutical industry, but they still remain a complicated area for pharma companies to address....
The Failure Rate at Phase Three is Probably 70% or Greater
January 03 by Surya Chitra, PhD, MBA, Biostatistics and Pharmacology, and Gary Fishbein, MD, MPH,Surya Chitra, PhD, MBA, Biostatistics and Pharmacology, and Gary Fishbein, MD, MPH, Senior Medical Director, PharmaNet Development Group, Inc, join Pharma IQ to discuss adaptive trial design. Pharma...
